Holen Sie sich die Stockscreener-App
68.15
0.89%
0.60
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CYTK?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$67.55
Offen:
$67.95
24-Stunden-Volumen:
1.95M
Relative Volume:
0.83
Marktkapitalisierung:
$8.33B
Einnahmen:
$18.47M
Nettoeinkommen (Verlust:
$-589.53M
KGV:
-12.96
EPS:
-5.26
Netto-Cashflow:
$-399.80M
1W Leistung:
+5.19%
1M Leistung:
+17.85%
6M Leistung:
+123.15%
1J Leistung:
+31.01%
1-Tages-Spanne:
$67.50
$68.91
1-Wochen-Bereich:
$62.86
$68.91
52-Wochen-Spanne:
$29.31
$68.91
Cytokinetics Inc Stock (CYTK) Company Profile
Firmenname
Cytokinetics Inc
Sektor
Branche
Telefon
(650) 624-3000
Adresse
350 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA
Vergleichen Sie CYTK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CYTK
Cytokinetics Inc
|
68.15 | 8.26B | 18.47M | -589.53M | -399.80M | -5.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
432.17 | 109.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.61 | 82.75B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
445.12 | 56.78B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.63 | 56.52B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.51 | 44.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cytokinetics Inc Stock (CYTK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-30 | Fortgesetzt | Raymond James | Mkt Perform |
| 2025-04-24 | Eingeleitet | Barclays | Overweight |
| 2025-02-07 | Eingeleitet | Citigroup | Buy |
| 2025-01-22 | Eingeleitet | Stifel | Buy |
| 2024-11-08 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-08-13 | Herabstufung | Goldman | Buy → Neutral |
| 2024-01-24 | Herabstufung | UBS | Buy → Neutral |
| 2024-01-05 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-09 | Eingeleitet | Goldman | Buy |
| 2023-11-07 | Eingeleitet | B. Riley Securities | Buy |
| 2023-08-15 | Eingeleitet | SVB Securities | Outperform |
| 2023-02-17 | Eingeleitet | BofA Securities | Neutral |
| 2022-12-23 | Bestätigt | Needham | Buy |
| 2022-12-20 | Eingeleitet | Truist | Buy |
| 2022-10-11 | Eingeleitet | UBS | Buy |
| 2022-01-28 | Eingeleitet | Goldman | Buy |
| 2021-12-22 | Eingeleitet | Oppenheimer | Outperform |
| 2021-12-10 | Eingeleitet | JP Morgan | Overweight |
| 2021-10-07 | Eingeleitet | Jefferies | Buy |
| 2021-03-12 | Eingeleitet | Wolfe Research | Outperform |
| 2021-02-18 | Eingeleitet | Barclays | Overweight |
| 2021-01-20 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-29 | Eingeleitet | Goldman | Neutral |
| 2020-07-10 | Eingeleitet | Raymond James | Strong Buy |
| 2020-05-05 | Eingeleitet | Mizuho | Buy |
| 2020-04-09 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-09-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-09-10 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2017-11-22 | Bestätigt | Morgan Stanley | Overweight |
| 2017-11-22 | Herabstufung | Needham | Strong Buy → Buy |
| 2017-11-21 | Bestätigt | H.C. Wainwright | Buy |
| 2017-07-31 | Eingeleitet | Morgan Stanley | Overweight |
| 2017-03-08 | Eingeleitet | Rodman & Renshaw | Buy |
| 2017-02-06 | Hochstufung | Needham | Buy → Strong Buy |
| 2016-12-16 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2016-07-28 | Bestätigt | Needham | Buy |
| 2015-11-10 | Bestätigt | FBR Capital | Outperform |
| 2015-11-09 | Bestätigt | ROTH Capital | Buy |
| 2015-07-24 | Bestätigt | MLV & Co | Buy |
| 2014-12-31 | Bestätigt | ROTH Capital | Buy |
| 2014-11-04 | Hochstufung | MLV & Co | Hold → Buy |
| 2014-04-28 | Bestätigt | Needham | Buy |
Alle ansehen
Cytokinetics Inc Aktie (CYTK) Neueste Nachrichten
Cytokinetics, Incorporated (CYTK) Stock Forecasts - Yahoo Finance
Important Notice to Long-Term Shareholders of Cytokinetics, - GlobeNewswire
Cytokinetics stock hits 52-week high at 68.48 USD By Investing.com - Investing.com Nigeria
How currency fluctuations impact Cytokinetics Incorporated stockJuly 2025 Momentum & Verified Stock Trade Ideas - BỘ NỘI VỤ
Cytokinetics Inc (KK3A.DU) stock price, news, quote and history - Yahoo Finance Singapore
Chronic Heart Failure Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveInsight - GlobeNewswire Inc.
Cytokinetics, Incorporated $CYTK Shares Acquired by Commonwealth of Pennsylvania Public School Empls Retrmt SYS - Defense World
Cytokinetics Shares Face Critical FDA Verdict - Ad-hoc-news.de
Cytokinetics, Incorporated (NASDAQ:CYTK) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
Revenue per share of Cytokinetics, Incorporated – BX:KK3A - TradingView
Ready to Jump After Recent Trade: Cytokinetics Inc (CYTK) - Setenews
Rep. Gilbert Ray Cisneros, Jr. Buys Cytokinetics, Incorporated (NASDAQ:CYTK) Stock - Defense World
How Cytokinetics Incorporated (KK3A) stock trades under stagflationWeekly Gains Report & Safe Capital Growth Trade Ideas - newser.com
What macro factors could drive Cytokinetics Incorporated (KK3A) stock higherJuly 2025 Action & Weekly Watchlist for Hot Stocks - newser.com
Insider Sell: B Parshall Sells 5,000 Shares of Cytokinetics Inc (CYTK) - GuruFocus
Is Cytokinetics Incorporated (KK3A) stock trading at attractive multiplesJuly 2025 Trade Ideas & Safe Entry Point Alerts - newser.com
[Form 4] CYTOKINETICS INC Insider Trading Activity - Stock Titan
Cytokinetics Director Sells 5,000 Shares - TradingView
Dir Parshall Sells 5,000 ($323.7K) Of Cytokinetics Inc [CYTK] - TradingView
What market sentiment indicators show for Cytokinetics Incorporated (KK3A) stock2025 Institutional Moves & High Yield Stock Recommendations - newser.com
Cytokinetics, IncorporatedCommon Stock (Nasdaq:CYTK) Stock Quote - Markets Financial Content
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea ... - Bluefield Daily Telegraph
Is Cytokinetics Incorporated (KK3A) stock prepared for digital transitionInsider Buying & Advanced Swing Trade Entry Plans - newser.com
Will Cytokinetics Incorporated (KK3A) stock draw ESG focused funds - newser.com
Cytokinetics Inc (KK3A.HM) Stock Historical Prices & Data - Yahoo! Finance Canada
Cytokinetics Inc (KK3A.HM) Latest Stock News & Headlines - Yahoo! Finance Canada
Cytokinetics Inc (KK3A.HM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Cytokinetics Inc (KK3A.HM) Interactive Stock Chart - Yahoo! Finance Canada
Insider Sell Alert: Fady Malik Sells 2,200 Shares of Cytokinetics Inc (CYTK) - GuruFocus
Cytokinetics announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Cytokinetics Executive Sells Shares - TradingView
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
Cytokinetics Grants Stock Options and RSUs to New Executive and Employees as Inducements to Employment - Quiver Quantitative
Cytokinetics (Nasdaq: CYTK) Grants 87,297 RSUs, Stock Options as Inducement Awards - Stock Titan
CYTK Deadline: CYTK Investors Have Opportunity to Lead Cytokinetics, Inc. Securities Fraud Lawsuit - The Malaysian Reserve
What Does the Market Think About Cytokinetics Inc? - Benzinga
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); enCore Energy ... - Bluefield Daily Telegraph
Lost Money on Cytokinetics, Incorporated (CYTK)? Urged to Join Class Action Before November 17, 2025 – Contact Levi & Korsinsky - ACCESS Newswire
Cytokinetics Incorporated (CYTK) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Investors in Cytokinetics, Incorporated Should Contact Levi & Korsinsky Before November 17, ... - Bluefield Daily Telegraph
Bragar Eagel & Squire, P.C. Urgently Reminds Investors of - GlobeNewswire
Total debt per share of Cytokinetics, Incorporated – DUS:KK3A - TradingView
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit - NewMediaWire
Recover Investment Losses: Class Action Initiated Against Cytokinetics, Incorporated (CYTK) - ACCESS Newswire
Cytokinetics at Jefferies London: Aficamten’s Strategic Path Forward By Investing.com - Investing.com Canada
Cytokinetics at Jefferies London: Aficamten’s Strategic Path Forward - Investing.com India
CYTK FINAL DEADLINE: Faruqi & Faruqi, LLP Announces that Cytokinetics Investors Have Opportunity to Lead Class Action Lawsuit - Business Wire
Cytokinetics at Jefferies London: Aficamten's Strategic Path Forward - Investing.com
Cytokinetics at Jefferies London: Aficamten's Strategic Path Forward By Investing.com - Investing.com Nigeria
CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
Portnoy Law Firm Announces Class Action on Behalf of Cytokinetics, Incorporated Investors - GlobeNewswire
Finanzdaten der Cytokinetics Inc-Aktie (CYTK)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.76%
2.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):